日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Combined inhibition of focal adhesion kinase and RAF/MEK elicits synergistic inhibition of melanoma growth and reduces metastases

联合抑制黏着斑激酶和RAF/MEK可协同抑制黑色素瘤生长并减少转移。

Jared Almazan ,Tursun Turapov ,David A Kircher ,Karly A Stanley ,Katie Culver ,A Paulina Medellin ,MiKaela N Field ,Gennie L Parkman ,Howard Colman ,Silvia Coma ,Jonathan A Pachter ,Sheri L Holmen

D-TERMINED, a phase 1 trial in newly diagnosed high-grade glioma with temozolomide, radiation, and minocycline followed by adjuvant minocycline/temozolomide

D-TERMINED,一项针对新诊断的高级别胶质瘤的 1 期临床试验,采用替莫唑胺、放射治疗和米诺环素治疗,随后进行辅助米诺环素/替莫唑胺治疗

William B McKean, Jingye Yang, Kenneth Boucher, Dennis C Shrieve, Gita Suneja, Karen Salzman, Randy Jensen, Howard Colman, Adam L Cohen

Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial

溶瘤 DNX-2401 病毒疗法联合帕博利珠单抗治疗复发性胶质母细胞瘤:一项 1/2 期试验

Farshad Nassiri, Vikas Patil, Leeor S Yefet, Olivia Singh, Jeff Liu, Rachel M A Dang, Takafumi N Yamaguchi, Mariza Daras, Timothy F Cloughesy, Howard Colman, Priya U Kumthekar, Clark C Chen, Robert Aiken, Morris D Groves, Shirley S Ong, Rohan Ramakrishna, Michael A Vogelbaum, Simon Khagi, Thomas Kal

A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastoma

基于 RNA 干扰的球形核酸在复发性胶质母细胞瘤患者中的首次人体 0 期临床研究

Priya Kumthekar, Caroline H Ko, Tatjana Paunesku, Karan Dixit, Adam M Sonabend, Orin Bloch, Matthew Tate, Margaret Schwartz, Laura Zuckerman, Ray Lezon, Rimas V Lukas, Borko Jovanovic, Kathleen McCortney, Howard Colman, Si Chen, Barry Lai, Olga Antipova, Junjing Deng, Luxi Li, Serena Tommasini-Ghelf

Prospective Feasibility Trial for Genomics-Informed Treatment in Recurrent and Progressive Glioblastoma

复发性和进展性胶质母细胞瘤的基因组学治疗前瞻性可行性试验

Sara A Byron, Nhan L Tran, Rebecca F Halperin, Joanna J Phillips, John G Kuhn, John F de Groot, Howard Colman, Keith L Ligon, Patrick Y Wen, Timothy F Cloughesy, Ingo K Mellinghoff, Nicholas A Butowski, Jennie W Taylor, Jennifer L Clarke, Susan M Chang, Mitchel S Berger, Annette M Molinaro, Gerald M

Mir-21-Sox2 Axis Delineates Glioblastoma Subtypes with Prognostic Impact

Mir-21-Sox2 轴描绘具有预后影响的胶质母细胞瘤亚型

Pratheesh Sathyan, Pascal O Zinn, Anantha L Marisetty, Bin Liu, Mohamed Mostafa Kamal, Sanjay K Singh, Pierre Bady, Li Lu, Khalida M Wani, Bethany L Veo, Joy Gumin, Dina Hamada Kassem, Frederick Robinson, Connie Weng, Veerabhadran Baladandayuthapani, Dima Suki, Howard Colman, Krishna P Bhat, Erik P

Intermittent induction of HIF-1α produces lasting effects on malignant progression independent of its continued expression

间歇性诱导 HIF-1α 对恶性进展产生持久影响,与其持续表达无关

Hyunsung Choi, David L Gillespie, Shauna Berg, Christopher Rice, Sandrine Couldwell, Jie Gu, Howard Colman, Randy L Jensen, L Eric Huang

Aberrant mesenchymal differentiation of glioma stem-like cells: implications for therapeutic targeting

胶质瘤干细胞样细胞的异常间充质分化:对治疗靶向的影响

Veerakumar Balasubramaniyan, Brian Vaillant, Shuzhen Wang, Joy Gumin, M Elena Butalid, Ke Sai, Farah Mukheef, Se Hoon Kim, H W G M Boddeke, Frederick Lang, Kenneth Aldape, Erik P Sulman, Krishna P Bhat, Howard Colman

A high Notch pathway activation predicts response to γ secretase inhibitors in proneural subtype of glioma tumor-initiating cells

高 Notch 通路激活可预测胶质瘤肿瘤起始细胞前神经亚型对 γ 分泌酶抑制剂的反应

Norihiko Saito, Jun Fu, Siyuan Zheng, Jun Yao, Shuzhen Wang, Diane D Liu, Ying Yuan, Erik P Sulman, Frederick F Lang, Howard Colman, Roel G Verhaak, W K Alfred Yung, Dimpy Koul

REST regulates oncogenic properties of glioblastoma stem cells

REST 调节胶质母细胞瘤干细胞的致癌特性

Mohamed M Kamal, Pratheesh Sathyan, Sanjay K Singh, Pascal O Zinn, Anantha L Marisetty, Shoudan Liang, Joy Gumin, Hala Osman El-Mesallamy, Dima Suki, Howard Colman, Gregory N Fuller, Frederick F Lang, Sadhan Majumder